Wall Street Journal has unveiled a report on outsourcing which states that companies’ high hopes of cost savings and attaining superior efficiency always does not materialize.
I have already discussed seven myths of outsourcing here. One would wonder, however, to what extent these myths actually impact pharmaceutical industries. Pharmacy companies are set to double outsource of R&D functions for next five 
years. Its an understood fact that if the processes go well, the volume may increase further and if it does not bring back good result, it will go down. Simple market dynamics. Most of the senior executives however are wishing for cheaper, quicker and more efficient result.
The WSJ study says, three main objectives of outsourcing - cost reductions, improvement in service, and flexibility - cannot be achieved at the same time.
To get News, views, analysis, joke, humor, even bitching of outsourcing world Subscribe here
Comment Preview